Phase 2 trial of durvalumab and radiation revaccination in patients with metastatic adenocarcinoma of the pancreas who have progressed through first-line chemotherapy. Article

cited authors

  • Chuong, Michael David; Badiyan, Shahed Nicolas; Mehta, Minesh P

fiu authors

publication date

  • February 1, 2019

Digital Object Identifier (DOI)

start page

  • tps461

end page

  • tps461


  • 37


  • 4_suppl